Table of Contents Author Guidelines Submit a Manuscript
Autism Research and Treatment
Volume 2014 (2014), Article ID 761279, 7 pages
http://dx.doi.org/10.1155/2014/761279
Research Article

Tsc2 Haploinsufficiency Has Limited Effects on Fetal Brain Cytokine Levels during Gestational Immune Activation

German Center for Neurodegenerative Diseases (DZNE), Ludwig-Erhard-Allee 2, 53175 Bonn, Germany

Received 9 April 2014; Accepted 20 June 2014; Published 9 July 2014

Academic Editor: Geraldine Dawson

Copyright © 2014 Dan Ehninger. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. D. Auerbach, E. K. Osterweil, and M. F. Bear, “Mutations causing syndromic autism define an axis of synaptic pathophysiology,” Nature, vol. 480, no. 7375, pp. 63–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Ehninger and A. J. Silva, “Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders,” Trends in Molecular Medicine, vol. 17, no. 2, pp. 78–87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. R. J. Kelleher III and M. F. Bear, “The autistic neuron: troubled translation?” Cell, vol. 135, no. 3, pp. 401–406, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Fombonne, “Epidemiological surveys of autism and other pervasive developmental disorders: an update,” Journal of Autism and Developmental Disorders, vol. 33, no. 4, pp. 365–382, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. S. L. Smalley, “Autism and tuberous sclerosis,” Journal of Autism and Developmental Disorders, vol. 28, no. 5, pp. 407–414, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. S. L. Smalley, P. E. Tanguay, M. Smith, and G. Gutierrez, “Autism and tuberous sclerosis,” Journal of Autism and Developmental Disorders, vol. 22, no. 3, pp. 339–355, 1992. View at Publisher · View at Google Scholar · View at Scopus
  7. M. G. Butler, M. J. Dazouki, X. Zhou et al., “Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations,” Journal of Medical Genetics, vol. 42, no. 4, pp. 318–321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Neves-Pereira, B. Müller, D. Massie et al., “Deregulation of EIF4E: a novel mechanism for autism,” Journal of Medical Genetics, vol. 46, no. 11, pp. 759–765, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. P. G. Williams and J. H. Hersh, “Brief report: the association of neurofibromatosis type 1 and autism,” Journal of Autism and Developmental Disorders, vol. 28, no. 6, pp. 567–571, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Ó. Atladóttir, P. Thorsen, L. Østergaard et al., “Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders,” Journal of Autism and Developmental Disorders, vol. 40, no. 12, pp. 1423–1430, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. R. J. Hagerman, A. W. Jackson III, A. Levitas, B. Rimland, and M. Braden, “An analysis of autism in fifty males with the fragile X syndrome,” American Journal of Medical Genetics, vol. 23, no. 1-2, pp. 359–374, 1986. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Chess, “Autism in children with congenital rubella,” Journal of Autism and Childhood Schizophrenia, vol. 1, no. 1, pp. 33–47, 1971. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Chess, “Follow up report on autism in congenital rubella,” Journal of Autism and Childhood Schizophrenia, vol. 7, no. 1, pp. 69–81, 1977. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Chess, P. Fernandez, and S. Korn, “Behavioral consequences of congenital rubella,” Journal of Pediatrics, vol. 93, no. 4, pp. 699–703, 1978. View at Publisher · View at Google Scholar · View at Scopus
  15. T. L. Sweeten, D. J. Posey, and C. J. McDougle, “Brief report: autistic disorder in three children with cytomegalovirus infection,” Journal of Autism and Developmental Disorders, vol. 34, no. 5, pp. 583–586, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Yamashita, C. Fujimoto, E. Nakajima, T. Isagai, and T. Matsuishi, “Possible association between congenital cytomegalovirus infection and autistic disorder,” Journal of Autism and Developmental Disorders, vol. 33, no. 4, pp. 455–459, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Garbett, P. J. Ebert, A. Mitchell et al., “Immune transcriptome alterations in the temporal cortex of subjects with autism,” Neurobiology of Disease, vol. 30, no. 3, pp. 303–311, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. T. Morgan, G. Chana, C. A. Pardo et al., “Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism,” Biological Psychiatry, vol. 68, no. 4, pp. 368–376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. P. H. Patterson, “Immune involvement in Schizophrenia and Autism: etiology, pathology and animal models,” Behavioural Brain Research, vol. 204, no. 2, pp. 313–321, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. D. L. Vargas, C. Nascimbene, C. Krishnan, A. W. Zimmerman, and C. A. Pardo, “Neuroglial activation and neuroinflammation in the brain of patients with autism,” Annals of Neurology, vol. 57, no. 1, pp. 67–81, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Voineagu, X. Wang, P. Johnston et al., “Transcriptomic analysis of autistic brain reveals convergent molecular pathology,” Nature, vol. 474, no. 7351, pp. 380–384, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. S. E. P. Smith, J. Li, K. Garbett, K. Mirnics, and P. H. Patterson, “Maternal immune activation alters fetal brain development through interleukin-6,” Journal of Neuroscience, vol. 27, no. 40, pp. 10695–10702, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Zuckerman and I. Weiner, “Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation,” Psychopharmacology, vol. 169, no. 3-4, pp. 308–313, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Ehninger, Y. Sano, P. J. De Vries et al., “Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice,” Molecular Psychiatry, vol. 17, no. 1, pp. 62–70, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. B. E. Deverman and P. H. Patterson, “Cytokines and CNS development,” Neuron, vol. 64, no. 1, pp. 61–78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Nawa, M. Takahashi, and P. H. Patterson, “Cytokine and growth factor involvement in schizophrenia—support for the developmental model,” Molecular Psychiatry, vol. 5, no. 6, pp. 594–603, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Shi, N. Tu, and P. H. Patterson, “Maternal influenza infection is likely to alter fetal brain development indirectly: the virus is not detected in the fetus,” International Journal of Developmental Neuroscience, vol. 23, no. 2-3, pp. 299–305, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Cao, S. Manicassamy, H. Tang et al., “Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway,” Nature Immunology, vol. 9, no. 10, pp. 1157–1164, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Colina, M. Costa-Mattioli, R. J. O. Dowling et al., “Translational control of the innate immune response through IRF-7,” Nature, vol. 452, no. 7185, pp. 323–328, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. U. Meyer, M. Nyffeler, A. Engler et al., “The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology,” Journal of Neuroscience, vol. 26, no. 18, pp. 4752–4762, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. J. de Miranda, K. Yaddanapudi, M. Hornig, G. Villar, R. Serge, and W. I. Lipkin, “Induction of toll-like receptor 3-mediated immunity during gestation inhibits cortical neurogenesis and causes behavioral disturbances,” mBio, vol. 1, no. 4, Article ID e00176-10, 2010. View at Publisher · View at Google Scholar
  32. L. Magri, M. Cominelli, M. Cambiaghi et al., “Timing of mTOR activation affects tuberous sclerosis complex neuropathology in mouse models,” Disease Models & Mechanisms, vol. 6, pp. 1185–1197, 2013. View at Google Scholar
  33. H. Soumiya, H. Fukumitsu, and S. Furukawa, “Prenatal immune challenge compromises the normal course of neurogenesis during development of the mouse cerebral cortex,” Journal of Neuroscience Research, vol. 89, no. 10, pp. 1575–1585, 2011. View at Publisher · View at Google Scholar · View at Scopus